227 related articles for article (PubMed ID: 17827739)
1. Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells.
Ishizu K; Sunose N; Yamazaki K; Tsuruo T; Sadahiro S; Makuuchi H; Yamori T
Biol Pharm Bull; 2007 Sep; 30(9):1779-83. PubMed ID: 17827739
[TBL] [Abstract][Full Text] [Related]
2. Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
Maki H; Hojo K; Tanaka H; Sawada TY; Maekawa R; Yoshioka T
Clin Exp Metastasis; 2002; 19(6):519-26. PubMed ID: 12405289
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts.
Azrak RG; Cao S; Slocum HK; Tóth K; Durrani FA; Yin MB; Pendyala L; Zhang W; McLeod HL; Rustum YM
Clin Cancer Res; 2004 Feb; 10(3):1121-9. PubMed ID: 14871992
[TBL] [Abstract][Full Text] [Related]
4. GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
Rick FG; Seitz S; Schally AV; Szalontay L; Krishan A; Datz C; Stadlmayr A; Buchholz S; Block NL; Hohla F
Cell Cycle; 2012 Nov; 11(22):4203-10. PubMed ID: 23095641
[TBL] [Abstract][Full Text] [Related]
5. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice.
Allegrini G; Goulette FA; Darnowski JW; Calabresi P
Cancer Chemother Pharmacol; 2004 Mar; 53(3):261-6. PubMed ID: 14658007
[TBL] [Abstract][Full Text] [Related]
7. Hepatic artery infusion for liver metastases from colorectal cancer.
Bonetti A
Lancet; 2003 Feb; 361(9355):358-9. PubMed ID: 12573366
[No Abstract] [Full Text] [Related]
8. Methods for evaluating effects of an irinotecan + 5-fluorouracil/leucovorin (IFL) regimen in an orthotopic metastatic colorectal cancer model utilizing in vivo bioluminescence imaging.
Surguladze D; Steiner P; Prewett M; Tonra JR
Methods Mol Biol; 2010; 602():235-52. PubMed ID: 20012402
[TBL] [Abstract][Full Text] [Related]
9. Rapid development of hepatic metastasis with high incidence following orthotopic transplantation of murine colon 38 carcinoma as intact tissue in syngeneic C57BL/6 mice.
Funahashi Y; Koyanagi N; Sonoda J; Kitoh K; Yoshimatsu K
J Surg Oncol; 1999 Jun; 71(2):83-90. PubMed ID: 10389863
[TBL] [Abstract][Full Text] [Related]
10. ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases.
Candeil L; Gourdier I; Peyron D; Vezzio N; Copois V; Bibeau F; Orsetti B; Scheffer GL; Ychou M; Khan QA; Pommier Y; Pau B; Martineau P; Del Rio M
Int J Cancer; 2004 May; 109(6):848-54. PubMed ID: 15027118
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan during pregnancy in metastatic colon cancer.
Cirillo M; Musola M; Cassandrini PA; Lunardi G; Venturini M
Tumori; 2012 Nov; 98(6):155e-7e. PubMed ID: 23389374
[TBL] [Abstract][Full Text] [Related]
12. Liver colonization competence governs colon cancer metastasis.
Kuo TH; Kubota T; Watanabe M; Furukawa T; Teramoto T; Ishibiki K; Kitajima M; Moossa AR; Penman S; Hoffman RM
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12085-9. PubMed ID: 8618849
[TBL] [Abstract][Full Text] [Related]
13. Chemoembolization of rat liver metastasis with irinotecan and quantification of tumor cell reduction.
Saenger J; Leible M; Seelig MH; Berger MR
J Cancer Res Clin Oncol; 2004 Apr; 130(4):203-10. PubMed ID: 14740207
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effect of camptothecin analog on liver metastatic model of human colon cancer in nude mice].
Takiguchi S; Shimazoe T; Kono A
Gan To Kagaku Ryoho; 1994 Apr; 21(5):705-8. PubMed ID: 8154898
[No Abstract] [Full Text] [Related]
15. Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models.
Zamboni WC; Stewart CF; Cheshire PJ; Richmond LB; Hanna SK; Luo X; Poquette C; McGovren JP; Houghton JA; Houghton PJ
Clin Cancer Res; 1998 Mar; 4(3):743-53. PubMed ID: 9533544
[TBL] [Abstract][Full Text] [Related]
16. Treatment of liver metastases of human colon cancers in nude mice with somatostatin analogue RC-160.
Qin Y; Schally AV; Willems G
Int J Cancer; 1992 Nov; 52(5):791-6. PubMed ID: 1358828
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of human colon tumor metastases to anticancer drugs in athymic (nude) mice.
Zirvi KA; Najjar TA; Slomiany BL
Cancer Lett; 1993 Aug; 72(1-2):39-44. PubMed ID: 8402572
[TBL] [Abstract][Full Text] [Related]
18. An orthotopic mouse model of remetastasis of human colon cancer liver metastasis.
Rashidi B; Gamagami R; Sasson A; Sun FX; Geller J; Moossa AR; Hoffman RM
Clin Cancer Res; 2000 Jun; 6(6):2556-61. PubMed ID: 10873112
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human cancer metastases by camptothecins in newly developed xenograft models.
Potmesil M; Vardeman D; Kozielski AJ; Mendoza J; Stehlin JS; Giovanella BC
Cancer Res; 1995 Dec; 55(23):5637-41. PubMed ID: 7585647
[TBL] [Abstract][Full Text] [Related]
20. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A
Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
